TY - JOUR
T1 - From biportal to uniportal video-assisted thoracoscopic anatomical lung resection A single-institute experience
AU - Chang, Jia Ming
AU - Kam, Kam Hong
AU - Yen, Yi Ting
AU - Huang, Wei Li
AU - Chen, Wei
AU - Tseng, Yau Lin
AU - Wu, Ming Ho
AU - Lai, Wu Wei
AU - Gonzalez-Rivas, Diego
N1 - Publisher Copyright:
© 2016 the Author(s). Published by Wolters Kluwer Health, Inc. All rights reserved.
PY - 2016
Y1 - 2016
N2 - Our study sought to review our experience from biportal to uniportal video-assisted thoracoscopic surgery (VATS) major lung resection. Lessons we learned from the evolution regarding technical aspects were also discussed. We retrospectively reviewed patients who underwent VATS lobectomy or segmentectomies in Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan, during January 2012 and December 2014. Patient clinical profiles, surgical indications and procedures, postoperative course, and oncological parameters were analyzed and compared between the biportal and uniportal groups. A total of 121 patients were enrolled in this study with median follow-up of 19.5±11.6 months for all patients and 22.5±11.5 months for primary lung cancer patients. Operation time (146.1±31.9-158.7±40.5 minutes; P=0.077), chest drainage time (3.8± 3.3-4.4±2.4 days; P=0.309), conversion to thoracotomy rate (2.2%-2.6%; P=0.889), and complication rate (15.6%-19.7%; P= 0.564) were equal between the groups, whereas blood loss (96.7±193.2-263.6±367; P=0.006) was lower in the uniportal group. For lung cancer cases, there were no statistical differences in the histology, cancer staging, mediastinal lymph node dissection stations, numbers of dissected N1, N2, and overall lymph nodes between uniportal and biportal groups. Our preliminary data showed that uniportal VATS anatomical lung resection is as feasible, equally safe, and of comparative oncological clearance efficacy to biportal VATS.
AB - Our study sought to review our experience from biportal to uniportal video-assisted thoracoscopic surgery (VATS) major lung resection. Lessons we learned from the evolution regarding technical aspects were also discussed. We retrospectively reviewed patients who underwent VATS lobectomy or segmentectomies in Ditmanson Medical Foundation Chia-Yi Christian Hospital, Chia-Yi, Taiwan, during January 2012 and December 2014. Patient clinical profiles, surgical indications and procedures, postoperative course, and oncological parameters were analyzed and compared between the biportal and uniportal groups. A total of 121 patients were enrolled in this study with median follow-up of 19.5±11.6 months for all patients and 22.5±11.5 months for primary lung cancer patients. Operation time (146.1±31.9-158.7±40.5 minutes; P=0.077), chest drainage time (3.8± 3.3-4.4±2.4 days; P=0.309), conversion to thoracotomy rate (2.2%-2.6%; P=0.889), and complication rate (15.6%-19.7%; P= 0.564) were equal between the groups, whereas blood loss (96.7±193.2-263.6±367; P=0.006) was lower in the uniportal group. For lung cancer cases, there were no statistical differences in the histology, cancer staging, mediastinal lymph node dissection stations, numbers of dissected N1, N2, and overall lymph nodes between uniportal and biportal groups. Our preliminary data showed that uniportal VATS anatomical lung resection is as feasible, equally safe, and of comparative oncological clearance efficacy to biportal VATS.
UR - http://www.scopus.com/inward/record.url?scp=84995608783&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=84995608783&partnerID=8YFLogxK
U2 - 10.1097/MD.0000000000005097
DO - 10.1097/MD.0000000000005097
M3 - Article
C2 - 27749589
AN - SCOPUS:84995608783
SN - 0025-7974
VL - 95
JO - Medicine (United States)
JF - Medicine (United States)
IS - 40
M1 - e5097
ER -